# Single Dose Amikacin for Uncomplicated Cystitis in the ED: A Feasibility Study

> **NCT05227937** · — · RECRUITING · sponsor: **Antonios Likourezos** · enrollment: 75 (estimated)

## Conditions studied

- Urinary Tract Infections

## Interventions

- **DRUG:** Amikacin

## Key facts

- **NCT ID:** NCT05227937
- **Lead sponsor:** Antonios Likourezos
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2022-09-21
- **Primary completion:** 2026-05-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 75 (ESTIMATED)
- **Last updated:** 2026-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05227937

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05227937, "Single Dose Amikacin for Uncomplicated Cystitis in the ED: A Feasibility Study". Retrieved via AI Analytics 2026-07-24 from https://api.ai-analytics.org/clinical/NCT05227937. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*